X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (2433) 2433
Publication (153) 153
Book Review (50) 50
Book Chapter (6) 6
Conference Proceeding (5) 5
Paper (3) 3
Book / eBook (1) 1
Magazine Article (1) 1
Streaming Video (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
alpha-tocopherol (1637) 1637
humans (1484) 1484
male (1131) 1131
animals (1066) 1066
index medicus (841) 841
female (763) 763
antioxidants - therapeutic use (748) 748
oxidative stress (675) 675
vitamin e - therapeutic use (672) 672
vitamin e (647) 647
antioxidants (594) 594
vitamin-e (540) 540
middle aged (489) 489
rats (467) 467
lipid-peroxidation (422) 422
pharmacology & pharmacy (391) 391
adult (371) 371
alpha-tocopherol - therapeutic use (352) 352
dietary supplements (351) 351
beta-carotene (334) 334
antioxidants - pharmacology (330) 330
aged (319) 319
tocopherols (292) 292
nutrition & dietetics (284) 284
oxidative stress - drug effects (266) 266
biochemistry & molecular biology (262) 262
mice (259) 259
antioxidant (252) 252
low-density-lipoprotein (229) 229
α-tocopherol (224) 224
health aspects (217) 217
rats, wistar (208) 208
double-blind method (201) 201
lipid peroxidation - drug effects (200) 200
diet (192) 192
oncology (190) 190
alpha-tocopherol - pharmacology (188) 188
vitamin e - analogs & derivatives (184) 184
antioxidants - metabolism (183) 183
vitamin e - administration & dosage (182) 182
antioxidants - administration & dosage (181) 181
ascorbic acid - therapeutic use (181) 181
lipid peroxidation (179) 179
vitamin e - pharmacology (179) 179
cancer (176) 176
alpha-tocopherol - analogs & derivatives (175) 175
atherosclerosis (171) 171
disease models, animal (169) 169
prevention (168) 168
supplementation (165) 165
tocopherol (162) 162
alpha-tocopherol - administration & dosage (156) 156
vitamin e - blood (156) 156
free radicals (155) 155
dose-response relationship, drug (153) 153
plasma (153) 153
risk factors (153) 153
risk (152) 152
cardiovascular-disease (150) 150
treatment outcome (150) 150
apoptosis (144) 144
toxicology (143) 143
research (141) 141
rats, sprague-dawley (135) 135
time factors (135) 135
endocrinology & metabolism (131) 131
alpha-tocopherol - blood (130) 130
analysis (126) 126
ascorbic-acid (122) 122
beta carotene - therapeutic use (115) 115
drug therapy, combination (113) 113
medicine, general & internal (113) 113
neurosciences (111) 111
in-vitro (109) 109
physiological aspects (109) 109
vitamins (109) 109
care and treatment (108) 108
adolescent (107) 107
glutathione (106) 106
oxidation-reduction (106) 106
reactive oxygen species - metabolism (106) 106
vitamins - therapeutic use (106) 106
article (105) 105
disease (104) 104
lipids (103) 103
inflammation (102) 102
free-radicals (101) 101
medicine (101) 101
vitamin c (101) 101
nutrition (98) 98
cell biology (96) 96
gamma-tocopherol (96) 96
rodents (96) 96
medicine, research & experimental (95) 95
administration, oral (94) 94
cells (94) 94
cholesterol (89) 89
liver - metabolism (89) 89
inhibition (86) 86
carotenoids (85) 85
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (2323) 2323
Russian (66) 66
Spanish (11) 11
Japanese (9) 9
Ukrainian (8) 8
Italian (5) 5
German (4) 4
French (3) 3
Polish (3) 3
Portuguese (2) 2
Chinese (1) 1
Czech (1) 1
Hungarian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Psychiatry and Clinical Neurosciences, ISSN 1323-1316, 06/2015, Volume 69, Issue 6, pp. 321 - 334
Tardive dyskinesia is a serious, disabling and potentially permanent, neurological hyperkinetic movement disorder that occurs after months or years of taking... 
first‐generation agents | schizophrenia | management | second‐generation agents | tardive dyskinesia | second-generation agents | first-generation agents | VITAMIN-E TREATMENT | NEUROTROPHIC FACTOR LEVELS | SCHIZOPHRENIC-PATIENTS | PSYCHIATRY | GINKGO-BILOBA | CHAIN AMINO-ACIDS | NEUROSCIENCES | ATYPICAL ANTIPSYCHOTICS | CLINICAL NEUROLOGY | HYPERKINETIC MOVEMENT-DISORDERS | DOUBLE-BLIND | PLACEBO-CONTROLLED TRIAL | ESSENTIAL FATTY-ACIDS | Stilbenes - therapeutic use | Antipsychotic Agents - adverse effects | Humans | Propranolol - therapeutic use | Leucine - therapeutic use | Dopamine Agents - therapeutic use | Amantadine - therapeutic use | Piracetam - therapeutic use | Pyridoxine - therapeutic use | Clonazepam - therapeutic use | Drugs, Chinese Herbal - therapeutic use | Adrenergic beta-Antagonists - therapeutic use | Adrenergic Uptake Inhibitors - therapeutic use | Anticonvulsants - therapeutic use | Nootropic Agents - therapeutic use | Isoleucine - therapeutic use | Vitamins - therapeutic use | Ginkgo biloba | alpha-Tocopherol - therapeutic use | Antioxidants - therapeutic use | Movement Disorders - etiology | Piracetam - analogs & derivatives | Melatonin - therapeutic use | Fatty Acids, Omega-3 - therapeutic use | Valine - therapeutic use | Isoxazoles - therapeutic use | Plant Extracts - therapeutic use | Movement Disorders - drug therapy | Tetrabenazine - therapeutic use | Schizophrenia | Movement disorders | Tardive dyskinesia | Medical research
Journal Article
Pakistan Journal of Medical Sciences, ISSN 1682-024X, 11/2018, Volume 34, Issue 6, pp. 1571 - 1575
Journal Article
JAMA, ISSN 0098-7484, 01/2009, Volume 301, Issue 1, pp. 39 - 51
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 11/2001, Volume 345, Issue 22, pp. 1583 - 1592
Journal Article
Journal Article